
pmid: 12041958
In the more than 40 years since the combined oral contraceptive pill was first marketed, much information has been obtained as to its risks. Considerably less publicity has been given to the balancing benefits that have also emerged. There has been an increasing realization that the risks are focused in those women with recognised risk factors, meaning that the remainder can use the product with increasing reassurance. The doses of both hormones have also been lowered considerably since the early years. Thus, it can be a rational decision by a fully informed woman to use this form of contraception.
Inflammation, Depressive Disorder, Digestive System Diseases, Libido, Corneal Edema, Jaundice, Nausea, Infections, Weight Gain, Skin Diseases, Contraceptives, Oral, Combined, Cardiovascular Diseases, Risk Factors, Neoplasms, Diabetes Mellitus, Humans, Drug Interactions, Female
Inflammation, Depressive Disorder, Digestive System Diseases, Libido, Corneal Edema, Jaundice, Nausea, Infections, Weight Gain, Skin Diseases, Contraceptives, Oral, Combined, Cardiovascular Diseases, Risk Factors, Neoplasms, Diabetes Mellitus, Humans, Drug Interactions, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 11 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
